Stat3 promotes invasion of esophageal squamous cell carcinoma through up-regulation of MMP2

Molecular Biology Reports

Volumn 42, Issue 5, 2015, Pages 907-915

  Xuan, Xaioyan ^a,b   Li, Shanshan ^a   Lou, Xi ^a   Zheng, Xianzhao ^a   Li, Yunyun ^a   Wang, Feng ^a   Gao, Yuan ^a   Zhang, Hongyan ^a   He, Hongliu ^a   Zeng, Qingru ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Esophagus; Invasion; MMP2; Squamous cell carcinoma; Stat3

Indexed keywords

GELATINASE A; MESSENGER RNA; STAT3 PROTEIN; MMP2 PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN;

ARTICLE; CELL INVASION; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CYTOPLASM; ESOPHAGEAL CANCER CELL LINE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION; ESOPHAGUS TUMOR; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; TUMOR INVASION;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; HUMANS; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; STAT3 TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 84937841647     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3828-8     Document Type: Article

References (44)

1. Lu JC, Tao H, Zhang YQ et al (2008) Extent of prophylactic postoperative radiotherapy after radical surgery of thoracic esophageal squamous cell carcinoma. Dis Esophagus 21:502–507
2. Pai A, Sonawane S, Purandare NC et al (2008) Penile metastasis from esophageal squamous carcinoma after curative resection. Ann Thorac Cardiovasc Surg 14:238–241
3. Darnell JE Jr (1997) STATs and gene regulation. Science 277:1630–1635
4. Santos CI, Costa-Pereira AP (2011) Signal transducers and activators of transcription—from cytokine signaling to cancer biology. Biochim Biophys Acta 1816:38–49
5. Jatiani SS, Baker SJ, Silverman LR, Reddy EP (2010) Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies. Genes Cancer 1:979–993
6. Hazan-Halevy I, Harris D, Liu Z et al (2010) STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells. Blood 115:2852–2863
7. Rani MR, Croze E, Wei T et al (2010) STAT-phosphorylation-independent induction of interferon regulatory factor-9 by interferon-beta. J Interferon Cytokine Res 30:163–1670
8. Escudero-Lourdes C, Medeiros MK, Cárdenas-González MC, Wnek SM, Gandolfi JA (2010) Low level exposure to monomethylarsonous acid-induced the over-production of inflammation-related cytokines and the activation of cell signals associated with tumor progression in an urothelial cell model. Toxicol Appl Pharmacol 244:162–173
9. Abdulghani J, Gu L, Dagvadorj A et al (2008) Stat3 promotes metastatic progression of prostate cancer. Am J Pathol 172:1717–1728
10. Bourguignon LYW, Peyrollier K, Xia W, Gilad E (2008) Hyaluronan–CD44 interaction activates stem cell marker nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Biol Chem 283:17635–17651
11. Zhang M, Zhu GY, Gao HY, Zhao SP, Xue Y (2011) Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma. J Surg Oncol 103:243–247
12. Roomi MW, Monterrey JC, Kalinovsky T, Rath M, Niedzwiecki A (2010) Inhibition of invasion and MMPs by a nutrient mixture in human cancer cell lines: a correlation study. Exp Oncol 32:243–248
13. Groblewska M, Mroczko B, Gryko M, Kędra B, Szmitkowski M (2010) Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients. Folia Histochem Cytobiol 48:564–571
14. He Y, Liu XD, Chen ZY et al (2007) Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis. Clin Cancer Res 13:3115–3124
15. Gupta GP, Nguyen DX, Chiang AC et al (2007) Mediators of vascular remodeling co-opted for sequential steps in lung metastasis. Nature 446:765–770
16. Xie T, Wei D, Liu M et al (2004) Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 23:3550–3560
17. Arnold MM, Srivastava S, Fredenburgh J, Stockard CR, Myers RB, Grizzle WE (1996) Effects of fixation and tissue processing on immunohistochemical demonstration of specific antigens. Biotech Histochem 71:23–224
18. Garner MM, Revzin A (1986) The use of gel electrophoresis to detect and study nucleic acid–protein interactions. Trends Biol Sci 11:395–396
19. Fried MG (1989) Measurement of protein–DNA interaction parameters by electrophoresis mobility shift assay. Electrophoresis 10:366–376
20. Becker S, Groner B, Muller CW (1998) Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature 394(6687):145–151
21. Brocklyn JR (2010) Regulation of cancer cell migration and invasion by sphingosine-1-phosphate. World J Biol Chem 1:307–312
22. Eigentler TK, Figl A, Krex D et al (2011) Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer 117:1697–1703
23. Lee SW, Jung KH, Jeong CH et al (2011) Inhibition of endothelial cell migration through the down-regulation of MMP-9 by A-kinase anchoring protein 12. Mol Med Rep 4:145–149
24. Stearns D, Chaudhry A, Abel TW, Burger PC, Dang CV, Eberhart CG (2006) c-Myc overexpression causes anaplasia in medulloblastoma. Cancer Res 66:673–681
25. He G, Karin M (2011) NF-κB and STAT3—key players in liver inflammation and cancer. Cell Res 21:159–168
26. Rosen DG, Mercado-Uribe I, Yang G et al (2006) The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Cancer 107:2730–2740
27. Tsareva SA, Moriggl R, Corvinus FM et al (2007) Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. Neoplasia 9:279–291
28. Proietti CJ, Béguelin W, Flaqué MC et al (2011) Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer. Steroids 76:381–392
29. Monnien F, Zaki H, Borg C et al (2010) Prognostic value of phosphorylated STAT3 in advanced rectal cancer: a study from 104 French patients included in the EORTC 22921 trial. J Clin Pathol 63:873–878
30. Chang KC, Wu MH, Jones D, Chen FF, Tseng YL (2006) Activation of STAT3 in thymic epithelial tumors correlates with tumor type and clinical behavior. J Pathol 210:224–233
31. Kusaba T, Nakayama T, Yamazumi K et al (2005) Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors. J Clin Pathol 58:833–838
32. Yang CH, Fan M, Slominski AT, Yue J, Pfeffer LM (2010) The role of constitutively activated STAT3 in B16 melanoma cells. Int J Infereron Cytokine Mediator Res 2:1–7
33. Ishdorj G, Johnston JB, Gibson SB (2010) Inhibition of constitutive activation of STAT3 by curcurbitacin-I (JSI-124) sensitized human B-leukemia cells to apoptosis. Mol Cancer Ther 9:3302–3314
34. Chen J, Wang J, Lin L et al (2012) Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer. Mol Cancer Ther 11:277–287
35. Wu ZS, Cheng XW, Wang XN, Song NJ (2011) Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma. Melanoma Res 21:483–490
36. Qian WF, Guan WX, Gao Y et al (2011) Inhibition of STAT3 by RNA interference suppresses angiogenesis in colorectal carcinoma. Braz J Med Biol Res 44:1222–1230
37. Silver DL, Naora H, Liu J, Cheng W, Montell DJ (2004) Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility. Cancer Res 64:3550–3558
38. Xie TX, Huang FJ, Aldape KD et al (2006) Activation of Stat3 in human melanoma promoter brain metastasis. Cancer Res 66:3188–3196
39. Scuto A, Krejci P, Popplewell L et al (2011) The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival. Leukemia 25:538–550
40. Che Y, Hou S, Kang Z, Lin Q (2009) Serenoa repens induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of STAT 3 signaling. Oncol Rep 22:377–383
41. Huang C, Yang G, Jiang T, Cao J, Huang KJ, Qiu ZJ (2011) Down-regulation of STAT3 expression by vector-based small interfering RNA inhibits pancreatic cancer growth. World J Gastroenterol 17:2992–3001
42. Blaskovich MA, Sun J, Cantor A, Turkson J, Jove R, Sebti SM (2003) Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res 63:1270–1279
43. Huang S, Chen M, Shen Y et al (2012) Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells. Cancer Lett 315:198–205
44. Glienke W, Maute L, Wicht J, Bergmann L (2010) Curcumin inhibits constitutive STAT3 phosphorylation in human pancreatic cancer cell lines and downregulation of survivin/BIRC5 gene expression. Cancer Invest 28:166–171